ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Esperion Therapeutics, Inc. clinical trials

Part of ARCHIMED, which holds 100% as of 2026-07-13. Source

The registry lists 24 studies whose lead sponsor is Esperion Therapeutics, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 17, 2026.

Keep track of what changes. Save the Esperion Therapeutics, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
23
Recruiting
1

Phase

Phase 2
12
Phase 3
7
Phase 1
3
Phase 4
1

Where

United States
23
Canada
4
United Kingdom
3
Netherlands
3
Germany
3
Spain
2

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Esperion Therapeutics, Inc..

  • Esperion Therapeutics, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies

Focus areas

Conditions Esperion Therapeutics, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Hypercholesterolemia13

Studies

Recruiting first, then most recently updated. Showing 24 of 24.